The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus
Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Postema, R., Townsend, R., Roudaut, M.Volume:
32
Language:
english
Journal:
Diabetic Medicine
DOI:
10.1111/dme.12772
Date:
July, 2015
File:
PDF, 373 KB
english, 2015